# Home BP Monitoring

Study · id `cardio:ct-nct05552547` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05552547](<https://clinicaltrials.gov/study/NCT05552547>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05552547

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 750 participants.

## Technical summary

Registry record NCT05552547. Non-randomized; no masking; primary purpose prevention. Start 2023-10-01 (actual); primary completion 2027-06-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 750 participants (planned count; ClinicalTrials.gov record NCT05552547, source copy `cardio:ctgov-nct05552547-2026-11-13`, retrieved 2026-11-18)
- Started: 2023-10-01 (actual) (ClinicalTrials.gov record NCT05552547, source copy `cardio:ctgov-nct05552547-2026-11-13`, retrieved 2026-11-18)
- Primary completion: 2027-06-01 (anticipated) (ClinicalTrials.gov record NCT05552547, source copy `cardio:ctgov-nct05552547-2026-11-13`, retrieved 2026-11-18)
- Completion: 2027-06-01 (anticipated) (ClinicalTrials.gov record NCT05552547, source copy `cardio:ctgov-nct05552547-2026-11-13`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT05552547, source copy `cardio:ctgov-nct05552547-2026-11-13`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05552547-2026-11-13`, retrieved 2026-11-18)

## The registry's words

- Brief title: Home BP Monitoring
- Condition: High Blood Pressure
- Intervention (Device): Home Blood Pressure Machine
- Intervention (Device): 24-Hour Blood Pressure Machine
- Lead sponsor: University Hospitals Cleveland Medical Center
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: University Hospitals Cleveland Medical Center (`cardio:org-university-hospitals-cleveland-medical-center`)

## Provenance

Content hash: b164f2408037728c824874101c0d4794aa8697736fafc366b1bfe7ea7f8594e1
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
